Hepatocellular Carcinoma — BCLC

Barcelona Clinic Liver Cancer staging, 2022 update
Tumour burden
Liver function (Child-Pugh)
Performance status (ECOG)

About this score

When to use

Stages hepatocellular carcinoma (BCLC 0, A, B, C, D) by tumour burden, liver function and performance status. ⁦[1]⁩

Pearls and pitfalls

The 2022 update subclassifies stage B and introduces stage migration. ⁦[1]⁩
Summarised from the numbered sources under Evidence. Check the source before relying on a statement.
Evidence
[1] Original publication
Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. Refines the mapping of tumour burden, liver function and performance status to stages 0/A/B/C/D and to first-line treatment, and adds a subclassification of stage B and the concept of stage migration.
Journal of Hepatology, 2022
Open source
Last reviewed: 2026-10
Report an error in this calculator
MedScore is an educational and clinical decision-support tool. It does not provide a diagnosis, a treatment, or a drug-dosing recommendation, and it does not replace clinical judgement or local guidelines. Confirm every result against the original source before acting on it. The treating clinician remains responsible for all decisions.
Support the developer
MedScore is free on the web and made by a medical student. If it helps you, you can support its development.
Support MedScore